Literature DB >> 9706719

Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis.

Y Boukaftane1, J Khoris, B Moulard, F Salachas, V Meininger, A Malafosse, W Camu, G A Rouleau.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the premature death of motor neurons. In approximately 10% of the cases the disease is inherited as autosomal dominant trait (FALS). It has been found that mutations in the Cu/Zn superoxide dismutase gene (SOD1) are responsible for approximately 15% of FALS kindreds. We screened affected individuals from 70 unrelated FALS kindreds and identified 10 mutations, 6 of which are novel. Surprisingly, we have found a mutation in exon 3, which includes most of the active site loop and Zn2+ binding sites, a region where no previous SOD1 mutations have been found. Our data increase the number of different SOD1 mutations causing FALS to 55, a significant fraction of the 154 amino acids of this relatively small protein.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706719     DOI: 10.1017/s0317167100034004

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  12 in total

1.  A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q.

Authors:  Collette K Hand; Jawad Khoris; François Salachas; François Gros-Louis; Ana Amélia Simões Lopes; Veronique Mayeux-Portas; Carl G Brewer; Robert H Brown; Vincent Meininger; William Camu; Guy A Rouleau
Journal:  Am J Hum Genet       Date:  2001-11-09       Impact factor: 11.025

Review 2.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

Review 3.  Clinical genetics of amyotrophic lateral sclerosis: what do we really know?

Authors:  Peter M Andersen; Ammar Al-Chalabi
Journal:  Nat Rev Neurol       Date:  2011-10-11       Impact factor: 42.937

Review 4.  Immature copper-zinc superoxide dismutase and familial amyotrophic lateral sclerosis.

Authors:  Sai V Seetharaman; Mercedes Prudencio; Celeste Karch; Stephen P Holloway; David R Borchelt; P John Hart
Journal:  Exp Biol Med (Maywood)       Date:  2009-07-13

Review 5.  Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene.

Authors:  Peter M Andersen
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

6.  Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.

Authors:  Joanna H Fanos; Susan Gronka; Joanne Wuu; Christine Stanislaw; Peter M Andersen; Michael Benatar
Journal:  Genet Med       Date:  2011-04       Impact factor: 8.822

7.  Human CCS gene: genomic organization and exclusion as a candidate for amyotrophic lateral sclerosis (ALS).

Authors:  Asli N Silahtaroglu; Karen Brondum-Nielsen; Ole Gredal; Lene Werdelin; Marios Panas; Michael B Petersen; Niels Tommerup; Zeynep Tümer
Journal:  BMC Genet       Date:  2002-04-19       Impact factor: 2.797

8.  Observation of c.260A > G mutation in superoxide dismutase 1 that causes p.Asn86Ser in Iranian amyotrophic lateral sclerosis patient and absence of genotype/phenotype correlation.

Authors:  Marzieh Khani; Afagh Alavi; Shahriar Nafissi; Elahe Elahi
Journal:  Iran J Neurol       Date:  2015-07-06

9.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

Review 10.  Is SOD1 loss of function involved in amyotrophic lateral sclerosis?

Authors:  Rachele A Saccon; Rosie K A Bunton-Stasyshyn; Elizabeth M C Fisher; Pietro Fratta
Journal:  Brain       Date:  2013-05-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.